(Q65390960)
Statements
A Partially Randomized, Partially Double-blind, Placebo-controlled Phase II Non-inferiority Study to Evaluate Immunogenicity and Safety of One and Two Doses of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in 18-55 Year Old Healthy Subjects (English)
0 references
April 2006
0 references
February 2007
0 references
745
0 references
18 year
0 references
55 year
0 references